<DOC>
	<DOC>NCT00921635</DOC>
	<brief_summary>The purpose of this study is to assess the feasibility, safety and short term effects on health related quality of life, of maintaining hemoglobin from 120 to 130 g/L versus from 100 to 110 g/L, with red cell concentrate (RCC) transfusion, in women having chemo-radiation for cancer of the cervix.</brief_summary>
	<brief_title>A Study to Evaluate the Impact of Maintaining Hemoglobin Levels in Anemic Patients With Carcinoma of the Cervix</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Benzocaine</mesh_term>
	<criteria>Previously untreated cervix cancer FIGO stage IB2, II, IIIB, IVA Suitable for treatment with radical intent using concurrent cisplatin and pelvic radiation Hemoglobin level above 125g/L Lower onethird vaginal involvement Paraaortic lymphadenopathy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Haemoglobin</keyword>
</DOC>